Try the modernized beta website. Learn more about the modernization effort.

Key Record Dates Identifier: NCT04816643
Brief Title: A Phase 1/2/3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Children and Young Adults

First Submitted : March 19, 2021
First Submitted that Met QC Criteria : March 24, 2021
First Posted : March 25, 2021

Last Update Submitted that Met QC Criteria : July 25, 2022
Last Update Posted : July 26, 2022